000 04137nam a22005055i 4500
001 978-0-387-36279-3
003 DE-He213
005 20161121230654.0
007 cr nn 008mamaa
008 100301s2006 xxu| s |||| 0|eng d
020 _a9780387362793
_9978-0-387-36279-3
024 7 _a10.1007/0-387-36279-3
_2doi
050 4 _aRC681-688.2
072 7 _aMJD
_2bicssc
072 7 _aMED010000
_2bisacsh
082 0 4 _a616.12
_223
245 1 0 _aBiochemistry of Atherosclerosis
_h[electronic resource] /
_cedited by Sukhinder Kaur Cheema.
264 1 _aBoston, MA :
_bSpringer US,
_c2006.
300 _aXVI, 572 p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aThe role of HDL in the prevention of atherosclerosis -- Cholesterol breakdown and the significance in atherosclerosis -- Triacylglycerol hydrolase, VLDL assembly and development of atherosclerosis -- Regulation of Hepatic Production of Lipoproteins Containing Apolipoprotein B and the significance in atherosclerosis -- Dyslipidemia and thrombogenesis -- Mouse models of Diabetes and Atherosclerosis -- Role of the unfolded protein response in atherosclerosis: a potential unifying theory of atherogenesis -- SR-BI, reverse cholesterol transport and atherogenesis -- Hypertension and atherosclerosis -- Dietary fats, transcription factors and heart health -- Dietary fatty acid intake and stroke -- Homocysteine metabolism and atherosclerosis -- Vitamin supplements in preventing atherosclerosis -- Oxidized lipids and heart disease -- Reverse cholesterol transport and prevention of atherosclerosis -- Homocysteine, diabetes mellitus and atherosclerosis -- Treating low HDL-From bench to bedside -- Atherosclerosis is an infectious disease.
520 _aAbout the Series: Advances in Biochemistry in Heath and Disease presents state-of-the-art discussions in cutting-edge biochemical research, offering exciting developments that impact healthcare and disease research. Volumes in the series focus on cross-disciplinary biomedical research and examine various topics in biochemistry, cell biology, molecular biology, and biomedicine. Biochemistry of Atherosclerosis Sukhinder Kaur Cheema Biochemistry of Atherosclerosis examines atherosclerosis in great detail, focusing on the risk of atherosclerosis, and the biochemical pathways involved. It provides a breadth of knowledge as well as new insights into a variety of topics relating to atherosclerosis from leading scientists around the world who are at the forefront of atherosclerosis research. Biochemistry of Atherosclerosis is essential reading for biomedical and clinical researchers. Key topics: Hyperlipidaemia and Atherosclerosis Diabetes Induced Atherosclerosis Hypertension Induced Atherosclerosis Homocysteine Metabolism and Atherosclerosis Role of the Immune System in Atherosclerosis Role of Infectious Agents in Atherogenesis Dietary Management of Aherosclerosis About the Editor: Sukhinder Kaur Cheema is currently Associate Professor of Biochemistry and a CIHR (Canadian Institutes of Health Research) New Investigator at the Memorial University of Newfoundland. An expert in nutritional biochemistry, lipid metabolism and cardiovascular disease, she is cross appointed in Faculty of Medicine at the Memorial University of Newfoundland.
650 0 _aMedicine.
650 0 _aMolecular biology.
650 0 _aCardiology.
650 0 _aBiochemistry.
650 0 _aCell biology.
650 0 _aDevelopmental biology.
650 1 4 _aMedicine & Public Health.
650 2 4 _aCardiology.
650 2 4 _aBiochemistry, general.
650 2 4 _aCell Biology.
650 2 4 _aMolecular Medicine.
650 2 4 _aDevelopmental Biology.
700 1 _aCheema, Sukhinder Kaur.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9780387312521
856 4 0 _uhttp://dx.doi.org/10.1007/0-387-36279-3
912 _aZDB-2-SBL
950 _aBiomedical and Life Sciences (Springer-11642)
999 _c502238
_d502238